Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone.
D000293:Adolescent; D000328:Adult; D003404:Creatinine / Q000097:blood; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D011507:Proteinuria / Q000378:metabolism
D003404:Creatinine; D008775:Methylprednisolone